P. aeruginosa Infection Increases Morbidity in Experimental Cholesteatomas

被引:21
|
作者
Jung, Jae Y. [1 ]
Lee, Dong H. [3 ]
Wang, Eric W. [1 ]
Nason, Robert [1 ]
Sinnwell, Toni M. [1 ]
Vogel, Joseph P. [3 ]
Chole, Richard A. [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63131 USA
[2] Washington Univ, Dept Dev Biol, St Louis, MO 63131 USA
[3] Washington Univ, Sch Med, Dept Microbiol, St Louis, MO 63131 USA
关键词
Cholesteatoma; P; aeruginosa; micro-CT; gerbil; bone resorption; PSEUDOMONAS-AERUGINOSA; OTITIS-MEDIA; MICROBIAL BIOFILMS; PNEUMOCYTE CELLS; ADHERENCE; VIRULENCE; PILIN;
D O I
10.1002/lary.22189
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: Clinicians have long noted that infected cholesteatomas are more aggressive than uninfected ones without data to support these observations. The purpose of this study is to determine the etiological role of biofilm forming P. aeruginosa (PA) and the virulence factor, type IV pili (TFP), in the pathogenesis of experimental cholesteatomas. Design: We evaluated three different PA strains and one Escherichia coli strain in cholesteatoma progression: PA14, a well-characterized wound isolate, OPPA8, an otopathogenic strain from a human cholesteatoma, OPPA8-NP, an isogenic TFP deletion mutant, and DH5 alpha, an E. coli strain. Methods: Cholesteatomas were induced in gerbils. We inoculated the right ear with bacteria and the left with vehicle. After 6 weeks their cholesteatomas were evaluated by micro-CT scanning. Cholesteatoma size and bone resorption were analyzed digitally. Results: Results demonstrate that PA infection increases cholesteatoma size when compared to uninfected controls: OPPA8 showed an 8.9-fold increase, PA14 a 2.6-fold increase, OPPA8-NP a 1.9-fold increase, while DH5a was not increased over controls. Additionally, infected bullae showed 10 to 50% more cholesteatoma-induced bone resorption. Conclusions: In this model, PA infected cholesteatomas enlarge more rapidly and are more destructive than uninfected controls. OPPA8, the strain from a human cholesteatoma, showed the greatest enlargement and bone destruction. Additionally, we demonstrate that TFP is a virulence factor in this model because the nonpiliated isogenic mutant, OPPA8-NP, was significantly less aggressive than the wild-type OPPA8 indicating that type IV pili may be a virulence factor in this disease.
引用
收藏
页码:2449 / 2454
页数:6
相关论文
共 50 条
  • [21] Tobramycin Inhalation Powder for P. aeruginosa Infection in Cystic Fibrosis: The EVOLVE Trial
    Konstan, Michael W.
    Geller, David E.
    Minic, Predrag
    Brockhaus, Florian
    Zhang, Jie
    Angyalosi, Gerhild
    PEDIATRIC PULMONOLOGY, 2011, 46 (03) : 230 - 238
  • [22] Synthesis and biological evaluation of thiazolidinedione derivatives with high ligand efficiency to P. aeruginosa PhzS
    Froes, Thamires Quadros
    Chaves, Bianca Trindade
    Mendes, Marina Sena
    Ximenes, Rafael Matos
    da Silva, Ivanildo Mangueira
    Gomes da Silva, Priscila Brandao
    Cavalcanti de Albuquerque, Julianna Ferreira
    Castilho, Marcelo Santos
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 1217 - 1229
  • [23] Resistance Patterns of P. aeruginosa in Various Settings in a Public Hospital in Alkharj, Saudi Arabia
    Ahmed, Nehad J.
    Haseeb, Abdul
    Hassali, Mohamed A.
    Elsaid, Enas E.
    Althemery, Abdullah U.
    Khan, Amer H.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2020, 39 (04): : 780 - 785
  • [24] Nanoscale effects of antibiotics on P. aeruginosa
    Formosa, Cecile
    Grare, Marion
    Duval, Raphael E.
    Dague, Etienne
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2012, 8 (01) : 12 - 16
  • [25] Identification of a novel RhlI/R-PrrH-LasI/Phzc/PhzD signalling cascade and its implication in P. aeruginosa virulence
    Lu, Yang
    Li, Honglin
    Pu, Jieying
    Xiao, Qian
    Zhao, Chanjing
    Cai, Yimei
    Liu, Yuyang
    Wang, Lina
    Li, Youqiang
    Huang, Bin
    Zeng, Jianming
    Chen, Cha
    EMERGING MICROBES & INFECTIONS, 2019, 8 (01) : 1658 - 1667
  • [26] SPECT Imaging of P. aeruginosa Infection in Mice Using 123I-BMIPP
    Nishiyama, Yuri
    Mizutani, Asuka
    Kobayashi, Masato
    Muranaka, Yuka
    Sato, Kakeru
    Maki, Hideki
    Kawai, Keiichi
    PHARMACEUTICS, 2024, 16 (05)
  • [27] A dose response model for the inhalation route of exposure to P. aeruginosa
    Dean, Kara
    Mitchell, Jade
    MICROBIAL RISK ANALYSIS, 2020, 15
  • [28] The effect of immobilisation strategies on the ability of peptoids to reduce the adhesion of P. aeruginosa strains to contact lenses
    Sara, Manjulatha
    Chakraborty, Sudip
    Chen, Renxun
    Palms, Dennis
    Katsifis, Georgio
    Li, Zhongyan
    Farajikhah, Syamak
    Massedupally, Vinod
    Hui, Alex
    Wong, Edgar H. H.
    Kumar, Naresh
    Vasilev, Krasimir
    Mackenzie, David
    Losurdo, Linda
    Dehghani, Farida
    Jenssen, Havard
    Sorensen, Kristian
    Lin, Jennifer S.
    Barron, Annelise E.
    Willcox, Mark
    EXPERIMENTAL EYE RESEARCH, 2025, 250
  • [29] EVALUATION OF PIPER BETLE L. EXTRACTS AND ITS ANTIVIRULENCE ACTIVITY TOWARDS P. AERUGINOSA
    Azahar, Nurul Izzati
    Mokhtar, Nadzirah Mohd
    Mahmood, Syed
    Abd Aziz, Mohd Aizudin
    Arifin, Mohd Azmir
    JURNAL TEKNOLOGI-SCIENCES & ENGINEERING, 2023, 85 (01): : 133 - 140
  • [30] Sub-Inhibitory Concentrations of Ciprofloxacin Alone and Combinations with Plant-Derived Compounds against P. aeruginosa Biofilms and Their Effects on the Metabolomic Profile of P. aeruginosa Biofilms
    Kart, Didem
    Recber, Tuba
    Nemutlu, Emirhan
    Sagiroglu, Meral
    ANTIBIOTICS-BASEL, 2021, 10 (04):